Ella Daly

6.2k total citations · 3 hit papers
64 papers, 3.3k citations indexed

About

Ella Daly is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Biological Psychiatry. According to data from OpenAlex, Ella Daly has authored 64 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pharmacology, 25 papers in Experimental and Cognitive Psychology and 18 papers in Biological Psychiatry. Recurrent topics in Ella Daly's work include Treatment of Major Depression (51 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (18 papers) and Tryptophan and brain disorders (18 papers). Ella Daly is often cited by papers focused on Treatment of Major Depression (51 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (18 papers) and Tryptophan and brain disorders (18 papers). Ella Daly collaborates with scholars based in United States, Belgium and United Kingdom. Ella Daly's co-authors include Jaskaran Singh, Madhukar H. Trivedi, Wayne C. Drevets, Husseini K. Manji, Pilar Lim, Maggie Fedgchin, Kimberly Cooper, Luc Van Nueten, Michael E. Thase and Rosanne Lane and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Journal of Affective Disorders.

In The Last Decade

Ella Daly

62 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression

2017 489 citations Ella Daly, Jaskaran Singh et al. JAMA Psychiatry profile →
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study

2019 483 citations Vanina Popova, Ella Daly et al. American Journal of Psychiatry profile →
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)

2019 297 citations Maggie Fedgchin, Madhukar H. Trivedi et al. The International Journal of Neuropsychopharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ella Daly United States	21	2.4k	1.6k	758	723	702	64	3.3k
Dawn F. Ionescu United States	32	2.1k 0.8×	1.6k 1.0×	821 1.1×	658 0.9×	646 0.9×	54	3.3k
Samuel T. Wilkinson United States	29	2.3k 1.0×	1.2k 0.7×	500 0.7×	584 0.8×	950 1.4×	89	3.3k
Rosanne Lane United States	23	1.8k 0.7×	1.2k 0.7×	508 0.7×	546 0.8×	1.2k 1.7×	41	3.2k
Nancy Diazgranados United States	25	2.6k 1.1×	2.2k 1.4×	574 0.8×	1.3k 1.8×	1.2k 1.6×	79	4.5k
Cristina Cusin United States	35	1.5k 0.6×	1.1k 0.7×	597 0.8×	1.0k 1.4×	1.4k 1.9×	102	3.8k
S. Danielle Canada	33	1.5k 0.6×	1.1k 0.7×	838 1.1×	317 0.4×	1.2k 1.8×	80	3.9k
Richard C. Shelton United States	31	1.5k 0.6×	1.1k 0.7×	561 0.7×	818 1.1×	905 1.3×	65	3.9k
Henrik Loft Denmark	29	1.8k 0.7×	543 0.3×	1.1k 1.4×	416 0.6×	923 1.3×	60	3.0k
Chiara Fabbri Italy	31	1.2k 0.5×	900 0.6×	494 0.7×	489 0.7×	1.0k 1.5×	155	3.1k
Manish K. Jha United States	30	1.3k 0.5×	1.3k 0.8×	741 1.0×	242 0.3×	664 0.9×	167	3.3k

Countries citing papers authored by Ella Daly

Since Specialization

Citations

This map shows the geographic impact of Ella Daly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ella Daly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ella Daly more than expected).

Fields of papers citing papers by Ella Daly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ella Daly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ella Daly. The network helps show where Ella Daly may publish in the future.

Co-authorship network of co-authors of Ella Daly

This figure shows the co-authorship network connecting the top 25 collaborators of Ella Daly. A scholar is included among the top collaborators of Ella Daly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ella Daly. Ella Daly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morrison, Randall L., Jaskaran Singh, Ella Daly, et al.. (2024). Effect of Esketamine Nasal Spray on Cognition in Patients With Treatment-Resistant Depression: Results From Four Phase 3 Studies. The International Journal of Neuropsychopharmacology. 27(11). 2 indexed citations

Kern, David M., Carla M. Canuso, Ella Daly, et al.. (2023). Suicide‐specific mortality among patients with treatment‐resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone. Brain and Behavior. 13(8). e3171–e3171. 18 indexed citations

Jamieson, Carol, Vanina Popova, Ella Daly, et al.. (2023). Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant. Health and Quality of Life Outcomes. 21(1). 40–40. 7 indexed citations

Turkoz, Ibrahim, Ella Daly, Jaskaran Singh, et al.. (2021). Treatment Response With Esketamine Nasal Spray Plus an Oral Antidepressant in Patients With Treatment-Resistant Depression Without Evidence of Early Response. The Journal of Clinical Psychiatry. 82(4). 17 indexed citations

Ochs-Ross, Rachel, Ewa Wajs, Ella Daly, et al.. (2021). Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy Study. American Journal of Geriatric Psychiatry. 30(5). 541–556. 27 indexed citations

Li, Qingqin S., Anna R. Docherty, Andrey A. Shabalin, et al.. (2021). 89. GENOME WIDE META-ANALYSIS OF SUICIDE BEHAVIORS. European Neuropsychopharmacology. 51. e88–e88. 1 indexed citations

Zhdanava, Maryia, Kruti Joshi, Ella Daly, et al.. (2020). Economic Burden of Treatment-Resistant Depression in Privately Insured U.S. Patients with Physical Conditions. Journal of Managed Care & Specialty Pharmacy. 26(8). 996–1007. 18 indexed citations

Katz, Eva G., Abigail I. Nash, Ella Daly, et al.. (2020). PMH51 WHAT ARE THE ATTRIBUTES THAT PSYCHIATRISTS CONSIDER IN THE DECISION TO DISCHARGE ADULTS WITH MAJOR DEPRESSIVE DISORDER WHO HAVE BEEN HOSPITALIZED WITH ACTIVE SUICIDAL IDEATION WITH INTENT?. Value in Health. 23. S210–S210. 1 indexed citations

Morrison, Robert M., Jaskaran Singh, Ella Daly, et al.. (2019). Effect of esketamine nasal spray on cognition in patients with treatment-resistant depression: results from five phase-3 studies. European Neuropsychopharmacology. 29. 1 indexed citations

10.

Popova, Vanina, Ella Daly, Madhukar H. Trivedi, et al.. (2019). Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study. American Journal of Psychiatry. 176(6). 428–438. 483 indexed citations breakdown →

11.

Daly, Ella, Jaskaran Singh, Maggie Fedgchin, et al.. (2017). Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression. JAMA Psychiatry. 75(2). 139–139. 489 indexed citations breakdown →

12.

Anghelescu, Ion‐George, Luc Janssens, Justine Kent, et al.. (2012). Does early improvement predict response to the fast-dissociating D2 receptor antagonist JNJ-37822681 in patients with acute schizophrenia? ☆. European Neuropsychopharmacology. 23(9). 1043–1050. 2 indexed citations

13.

Schmidt, Mark E., Justine Kent, Ella Daly, et al.. (2012). A double-blind, randomized, placebo-controlled study with JNJ-37822681, a novel, highly selective, fast dissociating D2 receptor antagonist in the treatment of acute exacerbation of schizophrenia. European Neuropsychopharmacology. 22(10). 721–733. 26 indexed citations

14.

Weisler, Richard H., Gahan Pandina, Ella Daly, Kimberly Cooper, & Cristiana Gassmann-Mayer. (2012). Randomized Clinical Study of a Histamine H3 Receptor Antagonist for the Treatment of Adults with Attention-Deficit Hyperactivity Disorder. CNS Drugs. 26(5). 421–434. 74 indexed citations

15.

Gollan, Jackie K., Maurizio Fava, Benji T. Kurian, et al.. (2011). What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression?. Depression and Anxiety. 29(2). 94–101. 27 indexed citations

16.

Daly, Ella, Madhukar H. Trivedi, Maurizio Fava, et al.. (2010). The Relationship Between Adverse Events During Selective Serotonin Reuptake Inhibitor Treatment for Major Depressive Disorder and Nonremission in the Suicide Assessment Methodology Study. Journal of Clinical Psychopharmacology. 31(1). 31–38. 16 indexed citations

17.

Trivedi, Madhukar H. & Ella Daly. (2008). Treatment strategies to improve and sustain remission in major depressive disorder.. PubMed. 10(4). 377–84. 54 indexed citations

18.

Daly, Ella. (2008). A review of quetiapine in combination with antidepressant therapy in patients with depression. Neuropsychiatric Disease and Treatment. Volume 3(6). 855–867. 18 indexed citations

19.

Trivedi, Madhukar H. & Ella Daly. (2007). Measurement-based care for refractory depression: A clinical decision support model for clinical research and practice. Drug and Alcohol Dependence. 88. S61–S71. 88 indexed citations

20.

Trivedi, Madhukar H., Cynthia A. Claassen, Bruce D. Grannemann, et al.. (2006). Assessing Physicians' Use of Treatment Algorithms: Project IMPACTS Study Design and Rationale. Contemporary Clinical Trials. 28(2). 192–212. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact